NCT05570604

Brief Summary

For millions of cancer survivors, cognitive impairment is a prevalent, severe, and persistent problem that is associated with other symptoms (depressive symptoms, anxiety and fatigue), poorer work ability, and poorer quality of life. Available evidence, including work by the investigators own group, suggests that cognitive training may be a viable treatment option. However, to date, these studies are limited as none have been conducted in the home and therefore fail to address the transferability of these empirically based cognitive training programs to general practice. The purpose of this translational research is to conduct a home based single-blind, randomized controlled trial to test the feasibility, satisfaction, and preliminary efficacy of cognitive training compared to attention control in breast cancer survivors (BCS) as well as to explore potential biomarkers of intervention effects. This research innovatively builds on investigator's previous research by: 1) translating findings from the laboratory to the home setting and importantly seeks to identify facilitators and barriers of intervention use; 2) addresses limitations of previous trials (uses an attention control rather than a no-contact or wait-list control), (3) examines cognitive training effects on real-life outcomes such as associated symptoms, perceived work ability and quality of life; and (4) will be the first study in cancer survivors to explore levels of BDNF as a potentially sensitive outcome measure of intervention effects over time compared to attention control. Findings from this study will provide necessary information about the feasibility, satisfaction and preliminary efficacy of the home-based cognitive training on memory performance and processing speed as well as its effects on associated outcomes in BCS. Positive results will lead to a larger, full-scale study to determine efficacy and build evidence-based treatment for clinicians to use in treating BCS with cognitive impairment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started May 2017

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 17, 2017

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2020

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

December 15, 2021

Completed
10 months until next milestone

First Posted

Study publicly available on registry

October 6, 2022

Completed
2.6 years until next milestone

Results Posted

Study results publicly available

April 24, 2025

Completed
Last Updated

April 24, 2025

Status Verified

April 1, 2025

Enrollment Period

2.8 years

First QC Date

December 15, 2021

Results QC Date

December 19, 2024

Last Update Submit

April 4, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Client Satisfaction Questionnaire

    Likert-based 8-item questionnaire rating overall satisfaction, quality of training, etc. 4-point scale (range from 8-32) with higher scores indicating greater acceptability and satisfaction.

    Within 1 week post-intervention

Secondary Outcomes (6)

  • Change in Patient Reported Outcomes Measurement Information System (PROMIS) Cognitive Abilities Between Baseline and 1 Week Post-intervention

    Baseline and within 1 week post-intervention

  • Change in Patient Reported Outcomes Measurement Information System (PROMIS) Cognitive Concerns Between Baseline and 1 Week Post-intervention

    Baseline and within 1 week post-intervention

  • Change in Work Ability Index (WAI) Between Baseline and 1 Week Post-intervention

    Baseline and within 1 week post-intervention

  • Change in Medical Outcomes Study-Short-Form Health Survey (MOS SF-36) General Perceptions of Health Between Baseline and 1 Week Post-intervention

    Baseline and within 1 week post-intervention

  • Change in Medical Outcomes Study-Short-Form Health Survey (MOS SF-36) Perceived Change in Health Between Baseline and 1 Week Post-intervention

    Baseline and within 1 week post-intervention

  • +1 more secondary outcomes

Other Outcomes (8)

  • Change in Rey Auditory Verbal Learning Test (Rey AVLT) Total Between Baseline and 1 Week Post-intervention

    Baseline and within 1 week post-intervention

  • Change in Rey Auditory Verbal Learning Test (Rey AVLT) Delayed Between Baseline and 1 Week Post-intervention

    Baseline and within 1 week post-intervention

  • Change in Rivermead Behavioral Paragraph Recall Test Between Baseline and 1 Week Post-intervention

    Baseline and within 1 week post-intervention

  • +5 more other outcomes

Study Arms (2)

Cognitive Training

EXPERIMENTAL

As tested in the investigator's pilot, the Brain HQ program is designed to enhance specific areas of cognitive functioning that will be tested in this study. The goals of the Brain HQ program are to improve visual processing speed, learning and memory and attention. The exercises include time-order judgment, discrimination, spatial-match, forward-span, instruction-following, and narrative-memory tasks. This program systematically reduces the stimulus duration during a series of increasingly difficult information-processing tasks presented via computer. The exercises automatically adjust to user performance to maintain an 85% correct rate. The program will include 4 hours per week over a 10-week period for a total of up to 40 hours. The study team has support from the original developer and Posit Science. For the purposes of this trial, any participants who do not complete the total of up to 40 hours will not be counted as deviations.

Behavioral: Sweep SeekerBehavioral: Bird SafariBehavioral: Jewel DiverBehavioral: Master GardenerBehavioral: Road Tour

Attention Control

PLACEBO COMPARATOR

Control participants will be asked to complete activities on the computer. The program offers a choice of activities that will consist of crossword puzzles and word jumbles. The program offers a pre-determined set of computerized crossword puzzles. The site has over 100,000 puzzles and can be accessed easily via the web and are free to users. The computerized crossword puzzles do not provide for progressive challenges of increasing speed, visual field size, number of distractors or degree of difficulty of targeted stimulus differentiation. Training: Participants will be instructed to perform this active attention control intervention 4 hours per week over 10 weeks for a total of up to 40 hours, the same as BrainHQ.

Behavioral: Computerized Crossword Puzzles

Interventions

Sweep SeekerBEHAVIORAL

The person is asked to clear the rows of blocks presented on the screen, either by moving them into horizontal or vertical blocks that have identical color. The goal is to refine and increase the response of primary visual cortex neurons and to enable the person to increase speed and accuracy of visual processing (executive function) and visual memory.

Cognitive Training
Bird SafariBEHAVIORAL

The user is first presented with a target bird. Subsequently, a group of birds is presented in the peripheral vision and then disappears when the trial begins. The user selects the section of the screen where the target bird appeared. The presentation speed adapts with user performance (i.e. better performance = faster presentation). The goal is to improve speed and accuracy of object identification in peripheral vision and improve visual precision important for improving memory.

Cognitive Training
Jewel DiverBEHAVIORAL

The person is first presented objects (jewels) on the screen. The objects are then covered with occluders (bubbles) and then identical distracters are presented. The objects move around in screen and when the movement stops, the user chooses the occluders that cover the jewels. The number of jewels adapts to performance (more jewels = better performance). The goal is to improve divided visual attention, sustained visual attention, visual working memory, and visual precision.

Cognitive Training
Master GardenerBEHAVIORAL

The person is presented a series of target stimuli and distracters which are presented at one time and then disappear. The locations of the stimuli are marked by icons, and the user chooses the icons where the target stimuli were once located. The goal is to increase speed and accuracy as well as the ability to extract information accurately.

Cognitive Training
Road TourBEHAVIORAL

The person is presented with a target vehicle briefly in both the center of the screen and in one of eight locations in the periphery. Two vehicles are then presented briefly in the center of the screen, one of which is the target vehicle. The user must identify the location of the target vehicle in the periphery as well as identify which was the target vehicle that appeared in the center. The goal of this activity is to improve divided attention and ability to extract information and discard irrelevant information from peripheral vision.

Cognitive Training

The program offers a pre-determined set of computerized crossword puzzles. The site has over 100,000 puzzles and can be accessed easily via the web and are free to users. The computerized crossword puzzles do not provide for progressive challenges of increasing speed, visual field size, number of distractors or degree of difficulty of targeted stimulus differentiation.

Attention Control

Eligibility Criteria

Age21 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female gender
  • ≥ 21 years old at the time of informed consent
  • Ability to provide written informed consent and HIPAA authorization
  • First diagnosis of non-metastatic breast cancer.
  • Self-reported cognitive impairment
  • Subjects seeking treatment though not currently being treated or with prior treatment history for cognitive impairment.
  • ≥ 1 year post-treatment including surgery, radiation, and/or chemotherapy
  • Ability to understand, speak, read, and write English

You may not qualify if:

  • Comorbidities that would sufficiently impair performance or inhibit cognitive training such as: history of stroke, encephalitis, traumatic brain injury, brain surgery, dementia, or Alzheimers disease.
  • Cranial radiation or intrathecal therapy.
  • Current active major depression or substance abuse or history of bipolar disorder psychosis, schizophrenia, or learning disability.
  • History of current or other cancer except for basal cell skin cancer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University School of Nursing

Indianapolis, Indiana, 46202, United States

Location

MeSH Terms

Conditions

Breast NeoplasmsCognitive Dysfunction

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesCognition DisordersNeurocognitive DisordersMental Disorders

Results Point of Contact

Title
Dr. Diane Von Ah
Organization
Ohio State University

Study Officials

  • Diane Von Ah, PhD

    Ohio State University College of Nursing.

    PRINCIPAL INVESTIGATOR
  • Tina Opoku, BS

    Ohio State University College of Nursing

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Masking Details
A blinded and trained tester will perform data collection and neuropsychological testing at two time points
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The purpose of this translational research is to conduct a home based single-blind, randomized controlled trial to test the feasibility, satisfaction, and preliminary efficacy of cognitive training compared to attention control in breast cancer survivors (BCS) as well as to explore potential biomarkers of intervention effects.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Distinguished Professor of Cancer Research, College of Nursing Director of Cancer Research Center for Healthy Aging, Self-Management and Complex Care

Study Record Dates

First Submitted

December 15, 2021

First Posted

October 6, 2022

Study Start

May 17, 2017

Primary Completion

March 20, 2020

Study Completion

March 20, 2020

Last Updated

April 24, 2025

Results First Posted

April 24, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

No identified data will be shared

Locations